Protocol: CDISCPILOT01                                                                  Page  1 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
CHEMISTRY 
---------- 
ALANINE AMINOTRANSFERASE  2 n 
 81 
  2 
 77 
  1 
 78 
  0 
 
 
Normal 81(100%)   0 
 77(100%)   0 
 78(100%)   0 
 
 
High   0 
  2(100%)   0 
  1(100%)   0 
  0 
 
 
 4 n 
 77 
  2 
 69 
  1 
 72 
  0 
 
 
Normal 77(100%)   1( 50%)  69(100%)   0 
 72(100%)   0 
 
 
High   0 
  1( 50%)   0 
  1(100%)   0 
  0 
 
 
 6 n 
 72 
  1 
 59 
  1 
 66 
  0 
 
 
Normal 71( 99%)   1(100%)  59(100%)   0 
 66(100%)   0 
 
 
High   1(  1%)   0 
  0 
  1(100%)   0 
  0 
 
 
 8 n 
 71 
  1 
 57 
  1 
 56 
  0 
 
 
Normal 71(100%)   0 
 57(100%)   0 
 54( 96%)   0 
 
 
High   0 
  1(100%)   0 
  1(100%)   2(  4%)   0 
 
 
12 n 
 66 
  1 
 49 
  1 
 50 
  0 
 
 
Normal 65( 98%)   1(100%)  48( 98%)   1(100%)  49( 98%)   0 
 
 
High   1(  2%)   0 
  1(  2%)   0 
  1(  2%)   0 
 
 
16 n 
 67 
  1 
 40 
  0 
 37 
  0 
 
 
Normal 67(100%)   1(100%)  40(100%)   0 
 37(100%)   0 
 
 
20 n 
 64 
  1 
 29 
  0 
 31 
  0 

--- Page 2 ---
Protocol: CDISCPILOT01                                                                  Page  2 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 64(100%)   1(100%)  29(100%)   0 
 31(100%)   0 
 
 
24 n 
 56 
  1 
 25 
  0 
 30 
  0 
 
 
Normal 55( 98%)   1(100%)  25(100%)   0 
 30(100%)   0 
 
 
High   1(  2%)   0 
  0 
  0 
  0 
  0 
 
 
26 n 
 56 
  1 
 24 
  0 
 27 
  0 
 
 
Normal 56(100%)   1(100%)  23( 96%)   0 
 27(100%)   0 
 
 
High   0 
  0 
  1(  4%)   0 
  0 
  0 
 
ALBUMIN 
 2 n 
 83 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 83(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 79 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 79(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 73 
  0 
 60 
  0 
 66 
  0 
 
 
Normal 73(100%)   0 
 60(100%)   0 
 66(100%)   0 
 
 
 8 n 
 72 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 72(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 

--- Page 3 ---
Protocol: CDISCPILOT01                                                                  Page  3 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
20 n 
 65 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 65(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 25 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 25(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 
 
ALKALINE PHOSPHATASE 
 2 n 
 82 
  2 
 78 
  0 
 77 
  1 
 
 
Normal 82(100%)   0 
 78(100%)   0 
 77(100%)   0 
 
 
High   0 
  2(100%)   0 
  0 
  0 
  1(100%) 
 
 
 4 n 
 80 
  2 
 69 
  0 
 71 
  1 
 
 
Normal 80(100%)   0 
 69(100%)   0 
 71(100%)   0 
 
 
High   0 
  2(100%)   0 
  0 
  0 
  1(100%) 
 
 
 6 n 
 75 
  0 
 62 
  0 
 66 
  1 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 66(100%)   0 
 
 
High   0 
  0 
  0 
  0 
  0 
  1(100%) 
 
 
 8 n 
 72 
  1 
 58 
  0 
 55 
  1 
 
 
Normal 72(100%)   0 
 57( 98%)   0 
 55(100%)   0 
 
 
High   0 
  1(100%)   1(  2%)   0 
  0 
  1(100%) 
 
 
12 n 
 66 
  1 
 50 
  0 
 49 
  1 

--- Page 4 ---
Protocol: CDISCPILOT01                                                                  Page  4 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 66(100%)   0 
 50(100%)   0 
 49(100%)   0 
 
 
High   0 
  1(100%)   0 
  0 
  0 
  1(100%) 
 
 
16 n 
 67 
  1 
 40 
  0 
 36 
  1 
 
 
Normal 67(100%)   0 
 40(100%)   0 
 36(100%)   0 
 
 
High   0 
  1(100%)   0 
  0 
  0 
  1(100%) 
 
 
20 n 
 64 
  1 
 30 
  0 
 30 
  1 
 
 
Normal 63( 98%)   0 
 30(100%)   0 
 30(100%)   0 
 
 
High   1(  2%)   1(100%)   0 
  0 
  0 
  1(100%) 
 
 
24 n 
 55 
  1 
 26 
  0 
 30 
  0 
 
 
Normal 54( 98%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
High   1(  2%)   1(100%)   0 
  0 
  0 
  0 
 
 
26 n 
 56 
  1 
 24 
  0 
 27 
  0 
 
 
Normal 55( 98%)   0 
 24(100%)   0 
 27(100%)   0 
 
 
High   1(  2%)   1(100%)   0 
  0 
  0 
  0 
 
ASPARTATE 
AMINOTRANSFERASE 
 2 n 
 81 
  2 
 78 
  0 
 78 
  0 
 
 
Normal 80( 99%)   1( 50%)  77( 99%)   0 
 78(100%)   0 
 
 
High   1(  1%)   1( 50%)   1(  1%)   0 
  0 
  0 
 
 
 4 n 
 77 
  2 
 69 
  1 
 72 
  0 
 
 
Normal 76( 99%)   1( 50%)  69(100%)   1(100%)  72(100%)   0 
 
 
High   1(  1%)   1( 50%)   0 
  0 
  0 
  0 

--- Page 5 ---
Protocol: CDISCPILOT01                                                                  Page  5 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
 6 n 
 72 
  1 
 60 
  0 
 66 
  0 
 
 
Normal 71( 99%)   1(100%)  60(100%)   0 
 65( 98%)   0 
 
 
High   1(  1%)   0 
  0 
  0 
  1(  2%)   0 
 
 
 8 n 
 71 
  1 
 58 
  0 
 56 
  0 
 
 
Normal 70( 99%)   1(100%)  58(100%)   0 
 55( 98%)   0 
 
 
High   1(  1%)   0 
  0 
  0 
  1(  2%)   0 
 
 
12 n 
 66 
  1 
 50 
  0 
 50 
  0 
 
 
Normal 65( 98%)   1(100%)  49( 98%)   0 
 50(100%)   0 
 
 
High   1(  2%)   0 
  1(  2%)   0 
  0 
  0 
 
 
16 n 
 67 
  1 
 40 
  0 
 37 
  0 
 
 
Normal 67(100%)   1(100%)  39( 98%)   0 
 37(100%)   0 
 
 
High   0 
  0 
  1(  3%)   0 
  0 
  0 
 
 
20 n 
 64 
  1 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   1(100%)  29(100%)   0 
 31(100%)   0 
 
 
24 n 
 56 
  1 
 25 
  0 
 30 
  0 
 
 
Normal 54( 96%)   1(100%)  24( 96%)   0 
 30(100%)   0 
 
 
High   2(  4%)   0 
  1(  4%)   0 
  0 
  0 
 
 
26 n 
 56 
  1 
 24 
  0 
 27 
  0 
 
 
Normal 55( 98%)   1(100%)  23( 96%)   0 
 27(100%)   0 
 
 
High   1(  2%)   0 
  1(  4%)   0 
  0 
  0 

--- Page 6 ---
Protocol: CDISCPILOT01                                                                  Page  6 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
BILIRUBIN 
 2 n 
 83 
  0 
 78 
  0 
 77 
  1 
 
 
Normal 82( 99%)   0 
 78(100%)   0 
 77(100%)   1(100%) 
 
 
High   1(  1%)   0 
  0 
  0 
  0 
  0 
 
 
 4 n 
 79 
  0 
 70 
  0 
 71 
  1 
 
 
Normal 78( 99%)   0 
 70(100%)   0 
 71(100%)   0 
 
 
High   1(  1%)   0 
  0 
  0 
  0 
  1(100%) 
 
 
 6 n 
 73 
  0 
 60 
  0 
 65 
  1 
 
 
Normal 73(100%)   0 
 60(100%)   0 
 65(100%)   1(100%) 
 
 
 8 n 
 72 
  0 
 58 
  0 
 55 
  1 
 
 
Normal 72(100%)   0 
 58(100%)   0 
 55(100%)   1(100%) 
 
 
12 n 
 67 
  0 
 50 
  0 
 49 
  1 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 48( 98%)   1(100%) 
 
 
High   0 
  0 
  0 
  0 
  1(  2%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 36 
  1 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 36(100%)   1(100%) 
 
 
20 n 
 65 
  0 
 29 
  0 
 30 
  1 
 
 
Normal 65(100%)   0 
 29(100%)   0 
 29( 97%)   1(100%) 
 
 
High   0 
  0 
  0 
  0 
  1(  3%)   0 
 
 
24 n 
 57 
  0 
 25 
  0 
 29 
  1 

--- Page 7 ---
Protocol: CDISCPILOT01                                                                  Page  7 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 57(100%)   0 
 25(100%)   0 
 29(100%)   1(100%) 
 
 
26 n 
 57 
  0 
 24 
  0 
 26 
  1 
 
 
Normal 57(100%)   0 
 23( 96%)   0 
 26(100%)   1(100%) 
 
 
High   0 
  0 
  1(  4%)   0 
  0 
  0 
 
CALCIUM 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 66 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 66(100%)   0 
 30(100%)   0 
 31(100%)   0 
 

--- Page 8 ---
Protocol: CDISCPILOT01                                                                  Page  8 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 
 
CHLORIDE 
 2 n 
 84 
  0 
 78 
  0 
 76 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 76(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 71 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 71(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 66 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 66(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 49 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 49(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 65 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 65(100%)   0 
 30(100%)   0 
 31(100%)   0 
 

--- Page 9 ---
Protocol: CDISCPILOT01                                                                  Page  9 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 
 
CHOLESTEROL 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 66 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 66(100%)   0 
 30(100%)   0 
 31(100%)   0 
 

--- Page 10 ---
Protocol: CDISCPILOT01                                                                  Page  10 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 
 
CREATINE KINASE 
 2 n 
 83 
  0 
 77 
  1 
 75 
  3 
 
 
Normal 81( 98%)   0 
 74( 96%)   1(100%)  74( 99%)   3(100%) 
 
 
High   2(  2%)   0 
  3(  4%)   0 
  1(  1%)   0 
 
 
 4 n 
 79 
  0 
 69 
  1 
 69 
  3 
 
 
Normal 78( 99%)   0 
 68( 99%)   1(100%)  68( 99%)   3(100%) 
 
 
High   1(  1%)   0 
  1(  1%)   0 
  1(  1%)   0 
 
 
 6 n 
 73 
  0 
 59 
  1 
 63 
  3 
 
 
Normal 73(100%)   0 
 58( 98%)   1(100%)  61( 97%)   2( 67%) 
 
 
High   0 
  0 
  1(  2%)   0 
  2(  3%)   1( 33%) 
 
 
 8 n 
 72 
  0 
 57 
  1 
 54 
  2 
 
 
Normal 71( 99%)   0 
 57(100%)   1(100%)  53( 98%)   2(100%) 
 
 
High   1(  1%)   0 
  0 
  0 
  1(  2%)   0 
 
 
12 n 
 67 
  0 
 49 
  1 
 48 
  2 
 
 
Normal 65( 97%)   0 
 48( 98%)   1(100%)  47( 98%)   1( 50%) 
 
 
High   2(  3%)   0 
  1(  2%)   0 
  1(  2%)   1( 50%) 
 
 
16 n 
 68 
  0 
 39 
  1 
 36 
  1 

--- Page 11 ---
Protocol: CDISCPILOT01                                                                  Page  11 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 66( 97%)   0 
 39(100%)   1(100%)  36(100%)   1(100%) 
 
 
High   2(  3%)   0 
  0 
  0 
  0 
  0 
 
 
20 n 
 65 
  0 
 29 
  0 
 30 
  1 
 
 
Normal 65(100%)   0 
 27( 93%)   0 
 29( 97%)   1(100%) 
 
 
High   0 
  0 
  2(  7%)   0 
  1(  3%)   0 
 
 
24 n 
 57 
  0 
 25 
  0 
 29 
  1 
 
 
Normal 55( 96%)   0 
 25(100%)   0 
 29(100%)   1(100%) 
 
 
High   2(  4%)   0 
  0 
  0 
  0 
  0 
 
 
26 n 
 57 
  0 
 24 
  0 
 26 
  1 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 25( 96%)   1(100%) 
 
 
High   0 
  0 
  0 
  0 
  1(  4%)   0 
 
CREATININE 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 

--- Page 12 ---
Protocol: CDISCPILOT01                                                                  Page  12 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 66 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 66(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 
 
GAMMA GLUTAMYL 
TRANSFERASE 
 2 n 
 82 
  2 
 76 
  2 
 76 
  2 
 
 
Normal 82(100%)   1( 50%)  75( 99%)   1( 50%)  75( 99%)   1( 50%) 
 
 
High   0 
  1( 50%)   1(  1%)   1( 50%)   1(  1%)   1( 50%) 
 
 
 4 n 
 80 
  2 
 68 
  2 
 70 
  2 
 
 
Normal 80(100%)   1( 50%)  68(100%)   1( 50%)  70(100%)   1( 50%) 
 
 
High   0 
  1( 50%)   0 
  1( 50%)   0 
  1( 50%) 
 
 
 6 n 
 74 
  1 
 61 
  1 
 66 
  1 
 
 
Normal 74(100%)   0 
 61(100%)   1(100%)  66(100%)   0 
 
 
High   0 
  1(100%)   0 
  0 
  0 
  1(100%) 

--- Page 13 ---
Protocol: CDISCPILOT01                                                                  Page  13 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
 8 n 
 72 
  1 
 57 
  1 
 55 
  1 
 
 
Normal 72(100%)   0 
 56( 98%)   1(100%)  54( 98%)   0 
 
 
High   0 
  1(100%)   1(  2%)   0 
  1(  2%)   1(100%) 
 
 
12 n 
 66 
  1 
 49 
  1 
 49 
  1 
 
 
Normal 66(100%)   0 
 49(100%)   1(100%)  49(100%)   0 
 
 
High   0 
  1(100%)   0 
  0 
  0 
  1(100%) 
 
 
16 n 
 67 
  1 
 39 
  1 
 36 
  1 
 
 
Normal 67(100%)   1(100%)  39(100%)   1(100%)  36(100%)   0 
 
 
High   0 
  0 
  0 
  0 
  0 
  1(100%) 
 
 
20 n 
 65 
  1 
 29 
  1 
 31 
  0 
 
 
Normal 65(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
High   0 
  1(100%)   0 
  1(100%)   0 
  0 
 
 
24 n 
 56 
  1 
 26 
  0 
 29 
  1 
 
 
Normal 54( 96%)   1(100%)  25( 96%)   0 
 29(100%)   0 
 
 
High   2(  4%)   0 
  1(  4%)   0 
  0 
  1(100%) 
 
 
26 n 
 56 
  1 
 24 
  0 
 26 
  1 
 
 
Normal 55( 98%)   1(100%)  23( 96%)   0 
 26(100%)   0 
 
 
High   1(  2%)   0 
  1(  4%)   0 
  0 
  1(100%) 
 
GLUCOSE 
 2 n 
 82 
  1 
 78 
  0 
 78 
  0 
 
 
Normal 82(100%)   1(100%)  78(100%)   0 
 77( 99%)   0 

--- Page 14 ---
Protocol: CDISCPILOT01                                                                  Page  14 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
High   0 
  0 
  0 
  0 
  1(  1%)   0 
 
 
 4 n 
 78 
  1 
 69 
  0 
 72 
  0 
 
 
Normal 78(100%)   1(100%)  69(100%)   0 
 72(100%)   0 
 
 
 6 n 
 72 
  1 
 60 
  0 
 66 
  0 
 
 
Normal 72(100%)   1(100%)  60(100%)   0 
 65( 98%)   0 
 
 
High   0 
  0 
  0 
  0 
  1(  2%)   0 
 
 
 8 n 
 71 
  1 
 57 
  0 
 56 
  0 
 
 
Normal 71(100%)   1(100%)  57(100%)   0 
 56(100%)   0 
 
 
12 n 
 66 
  1 
 50 
  0 
 49 
  0 
 
 
Normal 66(100%)   1(100%)  49( 98%)   0 
 49(100%)   0 
 
 
High   0 
  0 
  1(  2%)   0 
  0 
  0 
 
 
16 n 
 67 
  1 
 40 
  0 
 37 
  0 
 
 
Normal 67(100%)   1(100%)  40(100%)   0 
 37(100%)   0 
 
 
20 n 
 64 
  1 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   1(100%)  29(100%)   0 
 31(100%)   0 
 
 
24 n 
 56 
  1 
 25 
  0 
 30 
  0 
 
 
Normal 56(100%)   1(100%)  25(100%)   0 
 30(100%)   0 
 
 
26 n 
 56 
  1 
 24 
  0 
 27 
  0 
 
 
Normal 56(100%)   1(100%)  24(100%)   0 
 27(100%)   0 

--- Page 15 ---
Protocol: CDISCPILOT01                                                                  Page  15 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
PHOSPHATE 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 68 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 68(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 65 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 65(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 56 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 56(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 

--- Page 16 ---
Protocol: CDISCPILOT01                                                                  Page  16 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
POTASSIUM 
 2 n 
 84 
  0 
 78 
  0 
 76 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 76(100%)   0 
 
 
 4 n 
 82 
  0 
 68 
  0 
 71 
  0 
 
 
Normal 82(100%)   0 
 68(100%)   0 
 71(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 66 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 66(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 49 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 49(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 64 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 56 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 56(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 

--- Page 17 ---
Protocol: CDISCPILOT01                                                                  Page  17 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
PROTEIN 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 66 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 66(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 

--- Page 18 ---
Protocol: CDISCPILOT01                                                                  Page  18 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
SODIUM 
 2 n 
 84 
  0 
 78 
  0 
 76 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 76(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 71 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 71(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 66 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 66(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 49 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 49(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 65 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 65(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 

--- Page 19 ---
Protocol: CDISCPILOT01                                                                  Page  19 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
URATE 
 2 n 
 84 
  0 
 78 
  0 
 78 
  0 
 
 
Normal 84(100%)   0 
 78(100%)   0 
 78(100%)   0 
 
 
 4 n 
 82 
  0 
 70 
  0 
 72 
  0 
 
 
Normal 82(100%)   0 
 70(100%)   0 
 72(100%)   0 
 
 
 6 n 
 75 
  0 
 62 
  0 
 67 
  0 
 
 
Normal 75(100%)   0 
 62(100%)   0 
 67(100%)   0 
 
 
 8 n 
 73 
  0 
 58 
  0 
 56 
  0 
 
 
Normal 73(100%)   0 
 58(100%)   0 
 56(100%)   0 
 
 
12 n 
 67 
  0 
 50 
  0 
 50 
  0 
 
 
Normal 67(100%)   0 
 50(100%)   0 
 50(100%)   0 
 
 
16 n 
 68 
  0 
 40 
  0 
 37 
  0 
 
 
Normal 68(100%)   0 
 40(100%)   0 
 37(100%)   0 
 
 
20 n 
 66 
  0 
 30 
  0 
 31 
  0 
 
 
Normal 66(100%)   0 
 30(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 26 
  0 
 30 
  0 
 
 
Normal 57(100%)   0 
 26(100%)   0 
 30(100%)   0 
 
 
26 n 
 57 
  0 
 24 
  0 
 27 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 27(100%)   0 

--- Page 20 ---
Protocol: CDISCPILOT01                                                                  Page  20 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
UREA NITROGEN 
 2 n 
 84 
  0 
 76 
  2 
 78 
  0 
 
 
Normal 84(100%)   0 
 76(100%)   2(100%)  77( 99%)   0 
 
 
High   0 
  0 
  0 
  0 
  1(  1%)   0 
 
 
 4 n 
 82 
  0 
 68 
  2 
 72 
  0 
 
 
Normal 82(100%)   0 
 68(100%)   2(100%)  72(100%)   0 
 
 
 6 n 
 75 
  0 
 60 
  2 
 67 
  0 
 
 
Normal 75(100%)   0 
 60(100%)   2(100%)  67(100%)   0 
 
 
 8 n 
 73 
  0 
 56 
  2 
 56 
  0 
 
 
Normal 73(100%)   0 
 56(100%)   2(100%)  56(100%)   0 
 
 
12 n 
 67 
  0 
 49 
  1 
 50 
  0 
 
 
Normal 67(100%)   0 
 49(100%)   1(100%)  50(100%)   0 
 
 
16 n 
 68 
  0 
 39 
  1 
 37 
  0 
 
 
Normal 68(100%)   0 
 39(100%)   1(100%)  37(100%)   0 
 
 
20 n 
 66 
  0 
 29 
  1 
 31 
  0 
 
 
Normal 66(100%)   0 
 29(100%)   1(100%)  31(100%)   0 
 
 
24 n 
 57 
  0 
 25 
  1 
 30 
  0 
 
 
Normal 57(100%)   0 
 25(100%)   1(100%)  30(100%)   0 
 
 
26 n 
 57 
  0 
 23 
  1 
 27 
  0 

--- Page 21 ---
Protocol: CDISCPILOT01                                                                  Page  21 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 57(100%)   0 
 23(100%)   1(100%)  26( 96%)   0 
 
 
High   0 
  0 
  0 
  0 
  1(  4%)   0 
 
 
HEMATOLOGY 
---------- 
BASOPHILS 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 62 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 62(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 

--- Page 22 ---
Protocol: CDISCPILOT01                                                                  Page  22 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
EOSINOPHILS 
 2 n 
 82 
  0 
 76 
  1 
 77 
  0 
 
 
Normal 82(100%)   0 
 74( 97%)   1(100%)  77(100%)   0 
 
 
High   0 
  0 
  2(  3%)   0 
  0 
  0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 68( 99%)   0 
 
 
High   0 
  0 
  0 
  0 
  1(  1%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 62 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 58( 94%)   0 
 
 
High   0 
  0 
  0 
  0 
  4(  6%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 53( 95%)   0 
 52( 95%)   0 
 
 
High   0 
  0 
  3(  5%)   0 
  3(  5%)   0 
 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 46( 96%)   0 
 49(100%)   0 
 
 
High   0 
  0 
  2(  4%)   0 
  0 
  0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 

--- Page 23 ---
Protocol: CDISCPILOT01                                                                  Page  23 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 35( 97%)   0 
 
 
High   0 
  0 
  0 
  0 
  1(  3%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
ERY. MEAN CORPUSCULAR HB 
CONCENTRATION 
 2 n 
 82 
  0 
 76 
  0 
 76 
  0 
 
 
Normal 82(100%)   0 
 76(100%)   0 
 76(100%)   0 
 
 
 4 n 
 76 
  0 
 67 
  0 
 67 
  0 
 
 
Normal 76(100%)   0 
 67(100%)   0 
 67(100%)   0 
 
 
 6 n 
 71 
  0 
 57 
  0 
 63 
  0 
 
 
Normal 71(100%)   0 
 57(100%)   0 
 63(100%)   0 
 
 
 8 n 
 70 
  0 
 53 
  0 
 55 
  0 
 
 
Normal 70(100%)   0 
 53(100%)   0 
 55(100%)   0 
 
 
12 n 
 64 
  0 
 47 
  0 
 49 
  0 
 
 
Normal 64(100%)   0 
 47(100%)   0 
 49(100%)   0 

--- Page 24 ---
Protocol: CDISCPILOT01                                                                  Page  24 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 63 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 63(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 55 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 55(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
ERY. MEAN CORPUSCULAR 
HEMOGLOBIN 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 63 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 63(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 

--- Page 25 ---
Protocol: CDISCPILOT01                                                                  Page  25 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
ERY. MEAN CORPUSCULAR 
VOLUME 
 2 n 
 82 
  0 
 76 
  0 
 76 
  0 
 
 
Normal 82(100%)   0 
 76(100%)   0 
 76(100%)   0 
 
 
 4 n 
 76 
  0 
 67 
  0 
 67 
  0 
 
 
Normal 76(100%)   0 
 67(100%)   0 
 67(100%)   0 
 
 
 6 n 
 71 
  0 
 57 
  0 
 63 
  0 
 
 
Normal 71(100%)   0 
 57(100%)   0 
 63(100%)   0 
 
 
 8 n 
 70 
  0 
 53 
  0 
 55 
  0 
 
 
Normal 70(100%)   0 
 53(100%)   0 
 55(100%)   0 
 

--- Page 26 ---
Protocol: CDISCPILOT01                                                                  Page  26 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 64 
  0 
 47 
  0 
 49 
  0 
 
 
Normal 64(100%)   0 
 47(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 63 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 63(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 55 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 55(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
ERYTHROCYTES 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 63 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 63(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 

--- Page 27 ---
Protocol: CDISCPILOT01                                                                  Page  27 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
HEMATOCRIT 
 2 n 
 82 
  0 
 76 
  0 
 76 
  0 
 
 
Normal 82(100%)   0 
 76(100%)   0 
 76(100%)   0 
 
 
 4 n 
 76 
  0 
 67 
  0 
 67 
  0 
 
 
Normal 76(100%)   0 
 67(100%)   0 
 67(100%)   0 
 
 
 6 n 
 71 
  0 
 57 
  0 
 63 
  0 
 
 
Normal 71(100%)   0 
 57(100%)   0 
 63(100%)   0 
 
 
 8 n 
 70 
  0 
 53 
  0 
 55 
  0 
 
 
Normal 70(100%)   0 
 53(100%)   0 
 55(100%)   0 
 

--- Page 28 ---
Protocol: CDISCPILOT01                                                                  Page  28 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 64 
  0 
 47 
  0 
 49 
  0 
 
 
Normal 64(100%)   0 
 47(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 63 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 63(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 55 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 55(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
HEMOGLOBIN 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 63 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 63(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 

--- Page 29 ---
Protocol: CDISCPILOT01                                                                  Page  29 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
LEUKOCYTES 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 63 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 63(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 

--- Page 30 ---
Protocol: CDISCPILOT01                                                                  Page  30 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
LYMPHOCYTES 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 62 
  0 
 
 
Normal 72(100%)   0 
 59(100%)   0 
 62(100%)   0 
 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 70( 99%)   0 
 56(100%)   0 
 55(100%)   0 
 
 
High   1(  1%)   0 
  0 
  0 
  0 
  0 

--- Page 31 ---
Protocol: CDISCPILOT01                                                                  Page  31 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 64( 98%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
High   1(  2%)   0 
  0 
  0 
  0 
  0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
MONOCYTES 
 2 n 
 82 
  0 
 77 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 77(100%)   0 
 77(100%)   0 
 
 
 4 n 
 78 
  0 
 69 
  0 
 69 
  0 
 
 
Normal 78(100%)   0 
 69(100%)   0 
 69(100%)   0 
 
 
 6 n 
 72 
  0 
 59 
  0 
 62 
  0 
 
 
Normal 71( 99%)   0 
 59(100%)   0 
 62(100%)   0 
 
 
Low 
  1(  1%)   0 
  0 
  0 
  0 
  0 
 

--- Page 32 ---
Protocol: CDISCPILOT01                                                                  Page  32 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 8 n 
 71 
  0 
 56 
  0 
 55 
  0 
 
 
Normal 71(100%)   0 
 56(100%)   0 
 55(100%)   0 
 
 
12 n 
 65 
  0 
 48 
  0 
 49 
  0 
 
 
Normal 65(100%)   0 
 48(100%)   0 
 49(100%)   0 
 
 
16 n 
 67 
  0 
 39 
  0 
 36 
  0 
 
 
Normal 66( 99%)   0 
 39(100%)   0 
 36(100%)   0 
 
 
Low 
  1(  1%)   0 
  0 
  0 
  0 
  0 
 
 
20 n 
 64 
  0 
 29 
  0 
 31 
  0 
 
 
Normal 64(100%)   0 
 29(100%)   0 
 31(100%)   0 
 
 
24 n 
 57 
  0 
 24 
  0 
 29 
  0 
 
 
Normal 57(100%)   0 
 24(100%)   0 
 29(100%)   0 
 
 
26 n 
 56 
  0 
 24 
  0 
 26 
  0 
 
 
Normal 56(100%)   0 
 24(100%)   0 
 26(100%)   0 
 
PLATELET 
 2 n 
 82 
  0 
 74 
  0 
 77 
  0 
 
 
Normal 82(100%)   0 
 74(100%)   0 
 77(100%)   0 
 
 
 4 n 
 77 
  0 
 67 
  0 
 68 
  0 
 
 
Normal 77(100%)   0 
 67(100%)   0 
 68(100%)   0 
 
 
 6 n 
 72 
  0 
 57 
  0 
 61 
  0 
 
 
Normal 72(100%)   0 
 57(100%)   0 
 61(100%)   0 

--- Page 33 ---
Protocol: CDISCPILOT01                                                                  Page  33 of 33 
Population: Safety 
Table 14-6.04 
Shifts of Laboratory Values During Treatment, Categorized Based on Threshold Ranges, by Visit 
 
 
NOTES: Only subjects with baseline results are included in the summary. 
There were no subjects with abnormal low values at baseline. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rt_labshiftweek.sas           21:05 Monday, June 26, 2006 
 
Placebo (N=86)  
Xan. Low (N=84)  
Xan. High (N=84)  
 
___________________ 
___________________ 
___________________ 
 
Week 
Shift
 to 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
Normal at
Baseline 
High at 
Baseline 
 
 
 8 n 
 71 
  0 
 55 
  0 
 54 
  0 
 
 
Normal 71(100%)   0 
 55(100%)   0 
 54(100%)   0 
 
 
12 n 
 64 
  0 
 47 
  0 
 48 
  0 
 
 
Normal 64(100%)   0 
 47(100%)   0 
 48(100%)   0 
 
 
16 n 
 67 
  0 
 37 
  0 
 36 
  0 
 
 
Normal 67(100%)   0 
 37(100%)   0 
 36(100%)   0 
 
 
20 n 
 64 
  0 
 28 
  0 
 30 
  0 
 
 
Normal 64(100%)   0 
 28(100%)   0 
 30(100%)   0 
 
 
24 n 
 56 
  0 
 22 
  0 
 28 
  0 
 
 
Normal 56(100%)   0 
 22(100%)   0 
 28(100%)   0 
 
 
26 n 
 55 
  0 
 23 
  0 
 26 
  0 
 
 
Normal 55(100%)   0 
 23(100%)   0 
 26(100%)   0 
 
 
